The Scientist

» techniques, microbiology and disease/medicine

Most Recent

image: The Mechanobiology Garage

The Mechanobiology Garage

By | July 17, 2017

New tools for investigating how physical forces affect cells

0 Comments

image: Your Body Is Teeming with Weed Receptors

Your Body Is Teeming with Weed Receptors

By | July 17, 2017

And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.

1 Comment

image: Endocannabinoids in the Groove

Endocannabinoids in the Groove

By | July 17, 2017

The system responsible for the buzz humans get from marijuana plays a passel of physiological roles outside the brain.

0 Comments

image: Messing with the Microbiome

Messing with the Microbiome

By | July 17, 2017

Two new techniques allow researchers to manipulate the activity of gut bacteria. 

0 Comments

image: Mini-Metagenomics Leads to Microbial Discovery

Mini-Metagenomics Leads to Microbial Discovery

By | July 14, 2017

Researchers develop a method that combines the strengths of shotgun metagenomics and single-cell genome sequencing in a microfluidics-based platform.

0 Comments

image: Electrical Stimulation Steers Neural Stem Cells

Electrical Stimulation Steers Neural Stem Cells

By | July 3, 2017

Current can guide implanted cells away from rats’ noses toward a region deep in their brains.

0 Comments

image: Anti-Preeclampsia Hormone Discovered

Anti-Preeclampsia Hormone Discovered

By | June 29, 2017

A small, placenta-produced peptide fixes the pregnancy-related condition in mice. 

1 Comment

The discovery of peptides, enzymes, and other gene products that confer antibiotic resistance could give clues to how it develops.

1 Comment

image: Art’s Diagnosticians

Art’s Diagnosticians

By | June 12, 2017

Physicians peer into the subjects of artistic masterpieces, and find new perspective on their own approach to diagnosing maladies.

0 Comments

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

Popular Now

  1. So You’ve Been Mistaken as a White Nationalist
  2. Opinion: We Need a Replacement for Beall’s List
  3. Your Body Is Teeming with Weed Receptors
    Features Your Body Is Teeming with Weed Receptors

    And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.

  4. Doctors’ Advice to Finish Antibiotics Overlooks Resistance
AAAS